A recent study by Todenhoffer et al. [12], beginning with 808 patients suspected of having urothelial carcinoma was conducted to investigate the value of combinations of Cytology, uCytTM, FISH, and/or NMP22-ELISA in the diagnosis of bladder cancer (see Table 1). This evidence concerns the gene NUMA1 and urothelial carcinoma.